During the past decade, Privatklinik Wehrle-Diakonissen conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Privatklinik Wehrle-Diakonissen" are "Gastroparesis" (3 trials), "Diabetes Mellitus" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiovascular Diseases" (1 trials) and "Dyslipidemic" (1 trials). Many other conditions were trialed in "Privatklinik Wehrle-Diakonissen" in a lesser frequency.

Most popular intervention types in "Privatklinik Wehrle-Diakonissen" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Relamorelin" (2 trials), "BAY1213790 (Osocimab)" (1 trials), "Non-interventional" (1 trials) and "Relamorelin 10 μg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Privatklinik Wehrle-Diakonissen" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Privatklinik Wehrle-Diakonissen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Privatklinik Wehrle-Diakonissen, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Privatklinik Wehrle-Diakonissen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".